[ Price : $8.95]
Vanda Pharmaceuticals says FDA should withdraw a legislative proposal in its budget package that the company says would lengthen N...[ Price : $8.95]
FDA and the device industry are nearing a final agreement on the next round of Medical Device User Fee Act (MDUFA VI) negotiations...[ Price : $8.95]
Medline Industries recalls (Class 1) its angiographic control syringes, warning the devices could cause severe injury or death.[ Price : $8.95]
Law firm Sheppard breaks down some of FDAs proposals in its budget documents that industry should keep a close eye on, including n...[ Price : $8.95]
FDA announces a 5/18 virtual public workshop aimed at advancing the use of novel surrogate endpoints in developing treatments for ...[ Price : $8.95]
Insmed discontinues development of its drug candidate brensocatib for hidradenitis suppurativa after a mid-stage clinical trial fa...[ Price : $8.95]
Baker Hostetler attorney Winston Kirton says life sciences companies that are active in both the U.S. and the EU need to change th...[ Price : $8.95]
A Clinical Trial Vanguard online column explains how a 2022 FDA master protocol guidance has not kept pace with non-oncology baske...